| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence
|
Haarsma, R.
|
|
|
194 |
3 |
p. 617-627
|
artikel
|
| 2 |
Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations
|
Geczik, Ashley M.
|
|
|
194 |
3 |
p. 673-682
|
artikel
|
| 3 |
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer
|
Doney, Kristine
|
|
|
194 |
3 |
p. 507-516
|
artikel
|
| 4 |
A mixed method study of medical oncologists’ perceived barriers and motivators to addressing long-term effects in breast cancer survivors
|
Fauer, Alex J.
|
|
|
194 |
3 |
p. 699-707
|
artikel
|
| 5 |
Awareness of link between obesity and breast cancer risk is associated with willingness to participate in weight loss intervention
|
Burkbauer, Laura
|
|
|
194 |
3 |
p. 541-550
|
artikel
|
| 6 |
Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer
|
Corke, L.
|
|
|
194 |
3 |
p. 587-595
|
artikel
|
| 7 |
Comment on “Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis”
|
Poggio, Francesca
|
|
|
194 |
3 |
p. 709-710
|
artikel
|
| 8 |
Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
|
Chen, Lili
|
|
|
194 |
3 |
p. 517-529
|
artikel
|
| 9 |
Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel
|
Chen, Ciao-Sin
|
|
|
194 |
3 |
p. 551-560
|
artikel
|
| 10 |
Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density
|
Wernli, Karen J.
|
|
|
194 |
3 |
p. 607-616
|
artikel
|
| 11 |
Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis
|
Castelo, Matthew
|
|
|
194 |
3 |
p. 629-641
|
artikel
|
| 12 |
miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
|
Zhang, Zhuo
|
|
|
194 |
3 |
p. 483-505
|
artikel
|
| 13 |
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis
|
Sella, Tal
|
|
|
194 |
3 |
p. 597-606
|
artikel
|
| 14 |
Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017
|
Fwelo, Pierre
|
|
|
194 |
3 |
p. 643-661
|
artikel
|
| 15 |
Risk of secondary malignancy after radiotherapy for breast cancer: long-term follow-up of Japanese patients with breast cancer
|
Okonogi, Noriyuki
|
|
|
194 |
3 |
p. 561-567
|
artikel
|
| 16 |
Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy
|
Cheun, Jong-Ho
|
|
|
194 |
3 |
p. 683-692
|
artikel
|
| 17 |
Surveillance mammography after treatment for male breast cancer
|
Yadav, Siddhartha
|
|
|
194 |
3 |
p. 693-698
|
artikel
|
| 18 |
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
|
Skarping, Ida
|
|
|
194 |
3 |
p. 577-586
|
artikel
|
| 19 |
The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy
|
Sella, Tal
|
|
|
194 |
3 |
p. 663-672
|
artikel
|
| 20 |
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer
|
Vidula, Neelima
|
|
|
194 |
3 |
p. 569-575
|
artikel
|
| 21 |
Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting
|
Khoury, Thaer
|
|
|
194 |
3 |
p. 531-540
|
artikel
|
Tijdschrift beschrijving